EUCTR2013-005334-37-AT进行中（未招募）不适用
Effects of once-daily administered GLP-1 Receptoragonist Lixisenatide in combination with basal Insulin on glycemic control in patients with type-2 diabetes mellitus not achieving therapeutic targets with premixed insulin strategy - LixiBit
Medical University of Vienna / Medizinische Universität Wien0 个研究点开始时间: 2014年5月6日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Age 18 – 80a
- •Subjects understand study related activities and give written informed concent
- •HbA1c > 7% under treatment with premixed insulin (2-3 injections)
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 5
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 5
排除标准
- •Females of child-beering age
- •Impaired liver function (transaminase >2x than normal)
- •Impaired kidney funciton (creatinin > 1,5 mg/dl)
- •Known intolerance against GLP-1 receptor agonists
- •History of pancreatitis or pancreas tumor
- •Malignancies, autoimmune diseases
- •Severe dyslipidemia (serum triglycerides > 400 mg/dl, cholesterol > 300 mg/dl)
- •Psychiatric disorder
研究者
相似试验
招募中
不适用
Comparing effects of a long acting GLP-1 receptor agonist liraglutide with a short acting GLP-1 receptor agonist lixisenatide on diabetic cardiac autonomic neuropathy and glycemic variability evaluated by power spectral analysis of 24-hr heart rate and continuous glucose monitoring.Type 2 diabetesJPRN-UMIN000017144Department of Endocrinology and Metabolism, Dokkyo Medical University30
已完成
不适用
ong-term efficacy and safety of the GLP-1 receptor agonist liraglutide in Japanese patients with type 2 diabetes mellitus.Type 2 Diabetes mellitusJPRN-UMIN000037603akakinen clinic1,000
已完成
不适用
Comparison of the Effect of GLP-1 Receptor Agonists on Diurnal Glycemic Profiles in Patients with DiabetesInsulin-independent Diabetes MellitusJPRN-UMIN000007097Kitano Hospital, The Tazuke Kofukai Medical Research Institute40
招募中
不适用
Observation of using GLP-1 receptor agonist for wellness of brain activity in type 2 diabetes patients with mild cognitive impairmentJPRN-UMIN000030840Ogawa Red Cross Hospital50
进行中（未招募）
1 期
EFFECTS OF THE GLP-1 RECEPTOR AGONIST LIRAGLUTIDE ON LOWER LIMB PERFUSION IN PEOPLE WITH TYPE 2 DIABETES AND PERIPHERAL ARTERY DISEASE: A RANDOMIZED CONTROLLED TRIAPeripheral Artery Disease and type 2 diabetes mellitusMedDRA version: 20.0Level: LLTClassification code 10053246Term: Type II diabetes peripheral angiopathySystem Organ Class: 100000004866EUCTR2020-002940-22-ITA.O.U. Università degli Studi della Campania Luigi Vanvitelli50